+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA



Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA



Antiviral Research 134: 97-107



The development of new agents to target HBV cccDNA is urgently needed because of the limitations of current available drugs for treatment of hepatitis B. By using a cell-based assay in which the production of HBeAg is in a cccDNA-dependent manner, we screened a compound library derived from Chinese herbal remedies for inhibitors against HBV cccDNA. Three hydrolyzable tannins, specifically punicalagin, punicalin and geraniin, emerged as novel anti-HBV agents. These compounds significantly reduced the production of secreted HBeAg and cccDNA in a dose-dependent manner in our assay, without dramatic alteration of viral DNA replication. Furthermore, punicalagin did not affect precore/core promoter activity, pgRNA transcription, core protein expression, or HBsAg secretion. By employing the cell-based cccDNA accumulation and stability assay, we found that these tannins significantly inhibited the establishment of cccDNA and modestly facilitated the degradation of preexisting cccDNA. Collectively, our results suggest that hydrolyzable tannins inhibit HBV cccDNA production via a dual mechanism through preventing the formation of cccDNA and promoting cccDNA decay, although the latter effect is rather minor. These hydrolyzable tannins may serve as lead compounds for the development of new agents to cure HBV infection.

(PDF emailed within 0-6 h: $19.90)

Accession: 058039603

Download citation: RISBibTeXText

PMID: 27591143

DOI: 10.1016/j.antiviral.2016.08.026


Related references

Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrobial Agents and ChemoTherapy 56(8): 4277-4288, 2013

Punicalagin and punicalin, two tannins from pomegranate peel. Justus Liebigs Annalen der Chemie: 11 12 1976-1986, 1977

Punicalagin and punicalin 2 tannins from pomegranate peel. Justus Liebigs Annalen der Chemie (11-12): 1976-1986, 1977

Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. Journal of Virology 81(22): 12472-12484, 2007

Tannins and related compounds xl. revision of the structures of punicalin and punicalagin and isolation and characterization of 2 o galloylpunicalin from the bark of punica granatum. Chemical and Pharmaceutical Bulletin (Tokyo) 34(2): 650-655, 1986

Allele-specific polymerase chain reaction for detection of a mutation in the relax circular DNA and the covalently closed circular DNA of hepatitis B virus. Journal of Virological Methods 194(1-2): 277-279, 2014

G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. Journal Of Medical Virology. 55(1): 42-50,, 1998

Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B. Plos One 10(2): E0117741-E0117741, 2016

Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection. Intervirology 54(6): 316-325, 2012

Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma. Plos One 11(6): E0157708-E0157708, 2016

Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation. Journal of Gastroenterology and Hepatology 28(7): 1217-1222, 2014

Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients. Journal of Virological Methods 138(1-2): 70-79, 2006

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 40(3): 727-737, 2004

Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrobial Agents and ChemoTherapy 43(8): 2017-2026, 1999